Back
Astronics Corp. 10K Form
Buy
54
ATRO
Astronics Corp.
Last Price:
$55.67
Seasonality Move:
11.69%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-05-06 | 10Q | ATRO/Astronics Corp. Quarterly |
| 2023-11-09 | 10Q | ATRO/Astronics Corp. Quarterly |
| 2023-08-07 | 10Q | ATRO/Astronics Corp. Quarterly |
| 2023-05-10 | 10Q | ATRO/Astronics Corp. Quarterly |
| 2022-11-15 | 10Q | ATRO/Astronics Corp. Quarterly |
| 2022-08-11 | 10Q | ATRO/Astronics Corp. Quarterly |
Receive ATRO News And Ratings
See the #1 stock for the next 7 days that we like better than ATRO
ATRO Financial Statistics
Sales & Book Value
| Annual Sales: | $795.4M |
|---|---|
| Cash Flow: | $13.6M |
| Price / Cash Flow: | 48.44 |
| Annual Sales: | $3.07 |
| Price / Book: | 17.92 |
Profitability
| EPS (TTM): | -0.13570 |
|---|---|
| Net Income (TTM): | $-3.1M |
| Gross Margin: | $220.4M |
| Return on Equity: | -1.34% |
| Return on Assets: | -0.47% |
Astronics Corp. Earnings Forecast
Key Astronics Corp. Financial Ratios
-
The Gross Profit Margin over the past 41 years for ATRO is 27.71%.
-
The Selling, General & Administrative Expenses for ATRO have been equal to 17.84% of Gross Profit Margin.
-
The Research & Development expenses have been 6.55% of Revenue.
-
The Net Earning history of ATRO is -2.04% of Total Revenues.
-
Per Share Earnings over the last 41 years have been positive in 25 years.
Astronics Corp. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Aerospace & Defense |
| Sector: | Industrials |
| Current Symbol: | ATRO |
| CUSIP: | 046433 |
| Website: | astronics.com |
Debt
| Debt-to-Equity Ratio: | 3.48 |
|---|---|
| Current Ratio: | 2.87 |
| Quick Ratio: | 1.38 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 22.78 |
ATRO Technical Analysis vs Fundamental Analysis
Buy
54
Astronics Corp. (ATRO)
is a Buy
Is Astronics Corp. a Buy or a Sell?
-
Astronics Corp. stock is rated a BuyThe current Astronics Corp. [ATRO] share price is $54.79. The Score for ATRO is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.